Evoke Pharma Inc (EVOK) Live Share Price, Invest From India

Evoke Pharma Inc Stock Performance

as on December 17, 2025 at 7:57 am IST

Day's Low
$10.98
Day's Price Range
$11.00
$11.00
0.18%
Downside
52 Week's Low
$2.40
52-Week Price Range
$11.00
$11.00
78.18%
Downside

Evoke Pharma Inc share price movements today

Previous Close: $10.96
Open: $10.99
Volume: 345.8K
Day's Low - High: $10.98 - $11.00
52 Week Low - High: $2.40 - $11.00

Evoke Pharma Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Evoke Pharma Inc Stock Fundamentals & Key Indicators

Check Evoke Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Evoke Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evoke Pharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Evoke Pharma Inc	BUY	$-	NA	NA	0.00%
United Therapeutics Corporation	BUY	$24.7B	NA	20.88	41.94%
Haleon plc	BUY	$41.0B	NA	18.86	15.11%
Neurocrine Biosciences Inc	BUY	$13.5B	46.36%	28.65	16.73%
Zoetis Inc	BUY	$47.6B	-35.19%	18.72	28.24%

Analyst Recommendation on Evoke Pharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Evoke Pharma Inc. Average target price of $18

Evoke Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Evoke Pharma Inc.

What analysts predicted

38.89%UPSIDE

Target Price

$18

Current Price

$11

Analyzed by

7 Analysts

Target

$18.00

Evoke Pharma Inc target price $18, a slight upside of 38.89% compared to current price of $11. According to 7 analysts rating.

Evoke Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	1	1	1	1	2	2	3	3	3	4
Gross Profit	1	1	1	1	2	2	3	3	3	4
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Net Profit Margin	-165.10%	-108.39%	-118.58%	-91.03%	-49.67%	-49.45%	-36.05%	-42.41%	-41.87%	-26.99%

Evoke Pharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	0	1	2	5	10
Gross Profit	-	-	-	-	-	0	1	2	4	9
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-10	-12	-7	-7	-13	-8	-8	-7	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-57144.53%	-527.66%	-327.83%	-150.41%	-52.22%

Global Institutional Holdings in Evoke Pharma Inc

Funds	Holdings
Nantahala Capital Management, LLC	9.51%
Bleichroeder LP	4.41%
Citadel Advisors Llc	0.8%
Tower Research Capital LLC	0.13%
FMR Inc	0.02%

See all

Evoke Pharma Inc News & Key Events

Insights on Evoke Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, EVOK stock has moved up by 110.7%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.57M → -1.15M (in $), with an average increase of 35.9% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 3.08M → 4.28M (in $), with an average increase of 15.2% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, EVOK has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 88.1% return, outperforming this stock by 141.6%

About Evoke Pharma Inc

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. It develops, commercializes and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with pro-motility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti offers systemic delivery by nasal spray administration. It has developed a nasal formulation of metoclopramide to provide its targeted patient population with recurrent symptoms of diabetic gastroparesis with a product that is systemically delivered as an alternative to the oral or intravenous routes of administration. The nasal formulation delivers metoclopramide to patients with delayed gastric emptying and/or frequent vomiting.

Organisation	Evoke Pharma Inc
E-voting on shares	Click here to vote

FAQs

What is Evoke Pharma Inc share price today?

Evoke Pharma Inc share price today is $11 as on December 17, 2025 at 2:27 am IST at the close of the market. Evoke Pharma Inc share today touched a day high of $11 and a low of $10.98.

What is the 52 week high and 52 week low for Evoke Pharma Inc share?

Evoke Pharma Inc share touched a 52 week high of $11 on December 16, 2025 and a 52 week low of $2.4 on April 28, 2025. Evoke Pharma Inc stock price today i.e. December 17, 2025 at 2:27 am IST is closed at $11,which is 0.00% down from its 52 week high and 358.33% up from its 52 week low.

How to invest in Evoke Pharma Inc Stock (EVOK) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evoke Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evoke Pharma Inc Shares that will get you 0.1364 shares as per Evoke Pharma Inc share price of $11 per share as on December 17, 2025 at 2:27 am IST.

What is the minimum amount required to buy Evoke Pharma Inc Stock (EVOK) from India?

Indian investors can start investing in Evoke Pharma Inc (EVOK) shares with as little as ₹95.28 or $1 (as of May 5, 2026 at 5:06 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Evoke Pharma Inc stock (as per the Rupee-Dollar exchange rate as on May 5, 2026 at 5:06 pm IST). Based on Evoke Pharma Inc share’s latest price of $11 as on December 17, 2025 at 2:27 am IST, you will get 0.9091 shares of Evoke Pharma Inc. Learn more about fractional shares .